Federal Register / Vol. 89, No. 4 / Friday, January 5, 2024 / Notices 791 

1See https://www.federalregister.gov/documents/ 

2023/10/24/2023-23396/notice-of-request-forpublic-comment-on-proposed-update-to-the-brightfutures-periodicity-schedule. 

www.aap.org/en/patient-care/oralhealth/oral-health-practice-tools/ and 

refer to a dental home. Recommend 

brushing with fluoride toothpaste in the 

proper dosage for age. See ‘‘Maintaining 

and Improving the Oral Health of Young 

Children’’ (https://doi.org/10.1542/ 

peds.2022-060417). 

and 

Perform a risk assessment (https://

www.aap.org/en/patient-care/oralhealth/oral-health-practice-tools/). See 

‘‘Maintaining and Improving the Oral 

Health of Young Children’’ (https://

doi.org/10.1542/peds.2022-060417). 

Discussion of Recommended Updated 

Guidelines 

A Federal Register notice on October 

24, 2023, sought public comment on 

these proposed footnote updates (88 FR 

73034).1 The ICAPS Program considered 

all public comments as part of its 

deliberative process and provided the 

comments to HRSA for its 

consideration. A total of 25 respondents 

commented on one or more of the six 

proposed footnote updates. From the 25 

respondents, 119 responses were 

provided. Of these, 107 responses (89 

percent) expressed agreement and 13 

responses (11 percent) provided other 

comments or concerns. HRSA 

appreciates the comments in support of 

the updates. The additional comments 

and responses are summarized below. 

1. Footnote 4, relating to the first 

week well-child visit, also called the 3– 

5 Day Visit. 

20 respondents responded to this 

proposed footnote update, and 19 

indicated agreement. One respondent 

expressed concern that formal 

breastfeeding evaluation is not possible 

in every situation and suggested the 

proposed footnote include a qualified 

statement such as, ‘‘if services are 

available.’’ As this suggestion pertains 

to implementation and not the updated 

reference, the proposed footnote update 

will not be modified. 

2. Footnote 5, relating to Body Mass 

Index. 

18 respondents responded to this 

proposed footnote update, and 17 

indicated agreement. One respondent 

expressed concern regarding the use of 

BMI at the individual level to determine 

intervention for children. This 

suggestion does not align with the 

recommendation in the clinical practice 

guidelines, which is the updated 

reference within the proposed footnote 

change. The proposed footnote update 

will not be modified. 

3. Footnote 14, relating to Behavioral/ 

Social/Emotional Screening. 

20 respondents responded to this 

proposed footnote update, and 15 

indicated agreement. One respondent 

comment did not specifically address 

the proposed footnotes or the Bright 

Futures Periodicity Schedule and is 

therefore beyond the scope of the 

proposed updates. Three respondents 

expressed concerns related to 

implementation resources. As these 

suggestions pertain to implementation 

and not the additional reference that 

was added, the proposed footnote 

update will not be modified. One 

respondent suggested including the 

screening for anxiety in children under 

8 years of age. This suggestion does not 

align with the AAP clinical guidance or 

the updated USPSTF reference. The 

footnote update will be finalized as 

proposed. 

4. Footnote 15, relating to Tobacco, 

Alcohol, or Drug Use Assessment. 

20 respondents responded to this 

proposed footnote update and 17 

indicated agreement. Of the three 

respondents expressing concern, one 

respondent noted the need to ensure 

insurance companies do not violate the 

adolescent’s privacy to safely perform 

recommended preventive services. This 

suggestion is beyond the scope of the 

proposed footnote update and the 

proposed footnote update will not be 

modified. One respondent expressed 

concern with overprescribing naloxone 

and the potential to create drug shortage 

as well as suggesting the need for 

oversight with how to administer. The 

AAP has not found evidence supporting 

the concern of overprescribing in the 

pediatric primary care setting. The 

footnote will be finalized as proposed. 

Another respondent suggested removing 

‘‘prescribing’’ from the proposed 

footnote since naloxone is also available 

over the counter. This comment is 

reflected in the updated footnote 

language stating that providers should 

consider recommending or prescribing 

naloxone. The footnote will be finalized 

as proposed. 

5. Footnote 21, relating to Newborn 

Bilirubin Screening. 

20 respondents responded to this 

proposed footnote update and 18 

indicated agreement. Two respondents 

expressed concern about the 

implementation of this screening due to 

the cost and time for the primary care 

provider to obtain patient hospital 

records. As these suggestions pertain to 

implementation and not the updated 

reference. The proposed footnote update 

will not be modified. 

6. Footnote 35 and 36, relating to Oral 

Health. 

22 respondents responded to this 

proposed footnote update and 21 

indicated agreement. One respondent 

suggested adding the American 

Academy of Pediatric Dentistry (AAPD) 

recommendation that the first oral exam 

occur by age 12 months and that the 

interval of exams be based on the child’s 

individual needs or risk status and 

susceptibility to disease. The proposed 

footnote simply adds an updated 

reference to the latest AAP clinical 

report, which recommends a dental visit 

for children by 1 year of age. The 

proposed footnote update will not be 

modified in response to this comment. 

After consideration of public 

comment, the ICAPS Program submitted 

recommended footnote updates to 

HRSA for consideration, as detailed 

above. On December 29, 2023, the 

HRSA Administrator accepted the 

ICAPS Program recommendations and, 

as such, updated the HRSA-supported 

guidelines as set forth in the Bright 

Futures Periodicity Schedule. While 

non-grandfathered group health plans 

and health insurance issuers offering 

group or individual health insurance 

coverage must cover without costsharing the services and screenings 

listed as the HRSA-supported 

preventive services guidelines for 

infants, children, and adolescents as 

indicated above, these updates to the 

Bright Futures Periodicity Schedule 

footnotes do not change the clinical 

recommendations or the requirements 

for coverage without cost-sharing under 

section 2713 of the Public Health 

Service Act. Additional information 

regarding the ICAPS Program can be 

accessed at the following link: https://

mchb.hrsa.gov/maternal-child-healthtopics/child-health/bright-futures.html. 

Authority: Section 2713(a)(4) of the 

Public Health Service Act, 42 U.S.C. 

300gg–13(a)(4). 

Carole Johnson, 

Administrator. 

[FR Doc. 2024–00024 Filed 1–4–24; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Advisory Council on Alzheimer’s 

Research, Care, and Services; Meeting 

AGENCY: Assistant Secretary for 

Planning and Evaluation, HHS. 

ACTION: Notice of meeting. 

SUMMARY: This notice announces the 

public meeting of the Advisory Council 

on Alzheimer’s Research, Care, and 

Services (Advisory Council). The 

Advisory Council provides advice on 


lotter on DSK11XQN23PROD with NOTICES1
792 Federal Register / Vol. 89, No. 4 / Friday, January 5, 2024 / Notices 

how to prevent or reduce the burden of 

Alzheimer’s disease and related 

dementias (ADRD) on people with the 

disease and their caregivers. During the 

meeting on January 22, 2024, the 

Advisory Council will hear updates 

from the field on implementation of 

disease-modifying therapies for 

Alzheimer’s disease and outstanding 

research questions. A panel will present 

on the latest research on diagnosis and 

development of treatments for other 

populations and causes of dementia. 

DATES: The meeting will be January 22, 

2024 from 9:30 p.m. to 4:30 p.m. EST. 

ADDRESSES: The meeting will be a 

hybrid of in-person and virtual. The 

meeting will be held in Room 800 of the 

Hubert H. Humphrey Building, 200 

Independence Avenue SW, Washington, 

DC 20201. It will also stream live at 

www.hhs.gov/live. 

Comments: Time is allocated on the 

agenda to hear public comments from 

4:00 p.m. to 4:30 p.m. The time for oral 

comments will be limited to two (2) 

minutes per individual. In order to 

provide a public comment, please 

register by emailing your name to 

napa@hhs.gov by Wednesday, January 

17. Registered commenters will receive 

both a dial-in number and a link to join 

the meeting virtually; individuals will 

have the choice to either join virtually 

via the link, or to call in only by using 

the dial-in number. Note: There may be 

a 30–45 second delay in the livestream 

video presentation of the conference. 

For this reason, if you have preregistered to submit a public comment, 

it is important to connect to the meeting 

by 3:45 p.m. to ensure that you do not 

miss your name and allotted time when 

called. If you miss your name and 

allotted time to speak, you may not be 

able to make your public comment. 

Public commenters will not be admitted 

to the virtual meeting before 3:30 p.m. 

but are encouraged to watch the meeting 

at www.hhs.gov/live. Should you have 

questions during the session, please 

email napa@hhs.gov and someone will 

respond to your message as quickly as 

possible. 

In order to ensure accuracy, please 

submit a written copy of oral comments 

for the record by emailing napa@

hhs.gov by Tuesday, January 23, 2024. 

These comments will be shared on the 

website and reflected in the meeting 

minutes. 

In lieu of oral comments, formal 

written comments may be submitted for 

the record by Tuesday, January 23, 2024 

to Helen Lamont, Ph.D., OASPE, 200 

Independence Avenue SW, Room 424E, 

Washington, DC 20201. Comments may 

also be sent to napa@hhs.gov. Those 

submitting written comments should 

identify themselves and any relevant 

organizational affiliations. 

FOR FURTHER INFORMATION CONTACT: 

Helen Lamont, 202–260–6075, 

helen.lamont@hhs.gov. Note: The 

meeting will be available to the public 

live at www.hhs.gov/live. 

SUPPLEMENTARY INFORMATION: Notice of 

these meetings is given under the 

Federal Advisory Committee Act (5 

U.S.C. App. 2, section 10(a)(1) and 

(a)(2)). Topics of the Meeting: 

subcommittee recommendations, NIA 

bypass budget, FDA drug coverage 

decisions, and CDC Health Brain 

Initiative. 

Procedure and Agenda: The meeting 

will be webcast at www.hhs.gov/live and 

video recordings will be added to the 

National Alzheimer’s Project Act 

website when available after the 

meeting. This meeting is open to the 

public. Please allow 30 minutes to go 

through security and walk to the 

meeting room. Participants joining in 

person should note that seating may be 

limited. Those wishing to attend the 

meeting in person must send an email 

to napa@hhs.gov and put ‘‘January 22 

Meeting Attendance’’ in the subject line 

by Wednesday, January 17 so that their 

names may be put on a list of expected 

attendees and forwarded to the security 

officers at the Department of Health and 

Human Services. Any interested 

member of the public who is a non-U.S. 

citizen should include this information 

at the time of registration to ensure that 

the appropriate security procedure to 

gain entry to the building is carried out. 

Although the meeting is open to the 

public, procedures governing security 

and the entrance to Federal buildings 

may change without notice. If you wish 

to make a public comment, you must 

note that within your email. 

Authority: 42 U.S.C. 11225; Section 

2(e)(3) of the National Alzheimer’s 

Project Act. The panel is governed by 

provisions of Public Law 92–463, as 

amended (5 U.S.C. Appendix 2), which 

sets forth standards for the formation 

and use of advisory committees. 

Dated: December 22, 2023. 

Miranda Lynch-Smith, 

Deputy Assistant Secretary for Human 

Services Policy, Performing the Delegable 

Duties of the Assistant Secretary for Planning 

and Evaluation. 

[FR Doc. 2023–29020 Filed 1–4–24; 8:45 am] 

BILLING CODE 4150–05–P 

DEPARTMENT OF HOMELAND 

SECURITY 

U.S. Customs and Border Protection 

[OMB Control Number 1651–0074] 

Agency Information Collection 

Activities; Extension; Prior Disclosure 

AGENCY: U.S. Customs and Border 

Protection (CBP), Department of 

Homeland Security. 

ACTION: 60-Day notice and request for 

comments. 

SUMMARY: The Department of Homeland 

Security, U.S. Customs and Border 

Protection (CBP) will be submitting the 

following information collection request 

to the Office of Management and Budget 

(OMB) for review and approval in 

accordance with the Paperwork 

Reduction Act of 1995 (PRA). The 

information collection is published in 

the Federal Register to obtain comments 

from the public and affected agencies. 

DATES: Comments are encouraged and 

must be submitted (no later than March 

5, 2024) to be assured of consideration. 

ADDRESSES: Written comments and/or 

suggestions regarding the item(s) 

contained in this notice must include 

the OMB Control Number 1651–0074 in 

the subject line and the agency name. 

Please use the following method to 

submit comments: 

Email. Submit comments to: CBP_

PRA@cbp.dhs.gov. 

FOR FURTHER INFORMATION CONTACT: 

Requests for additional PRA information 

should be directed to Seth Renkema, 

Chief, Economic Impact Analysis 

Branch, U.S. Customs and Border 

Protection, Office of Trade, Regulations 

and Rulings, 90 K Street NE, 10th Floor, 

Washington, DC 20229–1177, 

Telephone number 202–325–0056 or via 

email CBP_PRA@cbp.dhs.gov. Please 

note that the contact information 

provided here is solely for questions 

regarding this notice. Individuals 

seeking information about other CBP 

programs should contact the CBP 

National Customer Service Center at 

877–227–5511, (TTY) 1–800–877–8339, 

or CBP website at https://www.cbp. 

gov/. 

SUPPLEMENTARY INFORMATION: CBP 

invites the general public and other 

Federal agencies to comment on the 

proposed and/or continuing information 

collections pursuant to the Paperwork 

Reduction Act of 1995 (44 U.S.C. 3501 

et seq.). This process is conducted in 

accordance with 5 CFR 1320.8. Written 

comments and suggestions from the 

public and affected agencies should 

address one or more of the following 


lotter on DSK11XQN23PROD with NOTICES1